Incyte
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 weeks.
- Recent price momentum is +1.4% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 5.2% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2849 U.S. stocks StockVane covers.
Last computed: 2026-11-21 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 58.5x | Better than 8% |
| Forward P/E | 22.4x | Better than 30% |
| Price / Sales | 4.1x | Better than 29% |
| P/E vs own 5-yr range | 80th pctl | Better than 27% |
Growth A-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 14.8% | Better than 75% |
| Net income CAGR (3Y) | 55.7% | Better than 89% |
| Free cash flow CAGR (3Y) | 14.2% | Better than 58% |
Profitability A+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 92.8% | Better than 97% |
| Operating margin | 26.1% | Better than 86% |
| Net margin | 25.0% | Better than 85% |
| Return on equity | 29.9% | Better than 87% |
| Return on invested capital | 27.7% | Better than 95% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -10.3% | Better than 50% |
| 6-month return | 18.0% | Better than 81% |
| 12-month return (ex latest month) | 14.6% | Better than 52% |
| Distance below 52-week high | 13.6% | Better than 75% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.3x | Better than 76% |
| Debt to assets | 0.6% | Better than 95% |
| Interest coverage | 686.5x | Better than 98% |
| Free cash flow / net income | 103.3% | Better than 40% |
Analyst View C
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 55.6% | Better than 33% |
| Upside to average target | 19.3% | Better than 31% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 115.87
- Open
- 116.85
- Day range
- 114.28 - 117.51
- Avg price
- 115.24
- Volume
- 1.54M
- Turnover
- 177.16M
- Turnover ratei
- 0.89%
- Volume ratioi
- 1.08
- Amplitudei
- 2.79%
- 52-week rangei
- 89.25 - 132.60
Valuation
- P/Ei
- 17.88
- P/E (TTM)i
- 58.48
- P/Bi
- 4.14
- EPSi
- 6.41
- Book value / shi
- 27.68
- Net profit
- 1.31B
- Net assets
- 5.64B
Share structure
- Market cap
- 23.36B
- Float capi
- 19.70B
- Shares out
- 203.83M
- Float sharesi
- 171.89M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
13.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+11.86M net over the window
Short interest
- Shares short
- 10.65M
- % of floati
- 5.22%
- Days to coveri
- 5.58
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Incyte (INCY)?
Incyte last traded at 114.63. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Incyte's market cap?
About 23.36B.
What is the P/E ratio of Incyte?
The trailing twelve-month P/E is 58.48, below its own 5-year average of 107.24 — toward the top of its historical range (79.92% percentile). See the Valuation tab for the full history.
Does Incyte pay a dividend?
Incyte does not currently pay a regular dividend.
Is Incyte a buy according to analysts?
The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 136.76, which implies 19.3% upside from the current price. This is not investment advice.
What is Incyte's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Incyte a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.
Incyte discussion 0 comments